Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ia trial of ORMD 0802 in healthy volunteers.

Next Previous
Trial Profile

Phase Ia trial of ORMD 0802 in healthy volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2009

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin (Primary)
  • Indications Diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Oramed Pharmaceuticals

Most Recent Events

  • 04 Feb 2009 Status changed from not yet recruiting to completed, as reported in an Oramed media release.
  • 29 Oct 2008 New trial record.
  • 23 Oct 2008 Approval received from the South Africa Medicines Control Council to begin testing of newly developed insulin suppository in volunteers, according to an Oramed Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top